Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2010
11/18/2010CA2761457A1 Immortalized avian cell lines and use thereof
11/18/2010CA2760465A1 Method for orthopoxvirus production and purification
11/17/2010EP2251419A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
11/17/2010EP2251036A1 Chimeric flavivirus vaccines
11/17/2010EP2250269A2 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
11/17/2010EP2250256A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells
11/17/2010EP2250255A2 Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof
11/17/2010EP2172227A9 Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby
11/17/2010EP1420821B1 Immunologically significant herpes simplex virus antigens and methods for using same
11/17/2010EP1276852B1 Viruses comprising mutated ion channel protein
11/17/2010CN101457215B Recombinant porcine pseudorabies virus-porcine propagate and breath complex virus-porcine circovirus genetic engineering strain and application
11/16/2010US7833788 immortalized human embryonic retinoblast cell; can be cultured under defined serum free conditions, and the cells show improved capability for propagating virus; eliminates the necessity to use whole chicken embryos for the production of influenza vaccines
11/16/2010US7833783 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
11/16/2010US7833774 use of such proteins in isolating various types of attenuated viruses for the development of vaccine and pharmaceutical formulations; protocols utilizing interferon antagonists, e.g., NS1, to enhance gene therapy or DNA vaccination based on their ability to increase gene expression
11/16/2010US7833753 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally
11/16/2010US7833741 Uncoupling of DNA insert propagation and expression of protein for phage display
11/16/2010US7833700 Kit for use in lysis and isolation of viral enzymatic polypeptides
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2428739C Complementing cell lines
11/16/2010CA2366861C Compositions and methods for helper-free production of recombinant adeno-associated viruses
11/14/2010CA2665599A1 Bacteriophage immobilization for biosensors
11/11/2010WO2010128100A1 Method for producing virus from cell culture involving homogenization
11/11/2010WO2010127474A1 A hepatitis b virus mutation strain with resistance to adefovir dipivoxil and the uses thereof
11/11/2010US20100287670 Protein expression system
11/11/2010US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations
11/11/2010US20100287633 Hyperactive PiggyBac Transposases
11/11/2010US20100285570 Fluoride processing method
11/11/2010US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
11/11/2010US20100285444 HBV precore protein capable of forming particles
11/11/2010US20100285063 Novel canine influenza virus and vaccine therefore
11/11/2010US20100285059 Cytomegalovirus Vaccines and Methods of Production
11/11/2010US20100285056 Baculovirus-Based Vaccines
11/11/2010US20100284975 Polypeptides comprising fas activation and nkg2d-ligand domains
11/11/2010US20100284974 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
11/11/2010US20100284967 Modified phage for displaying post-translationally modified proteins and uses thereof
11/11/2010CA2760787A1 Combined measles-malaria vaccine
11/11/2010CA2760657A1 Method for producing virus from cell culture involving homogenization
11/11/2010CA2759801A1 Gene therapy for neurodegenerative disorders
11/10/2010EP2248890A1 Bacteriophages specific to PAK and CHA strains of Pseudomonas aeruginosa and their applications
11/10/2010EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN101883858A Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof
11/10/2010CN101883857A Simian subfamily B adenoviruses SAdV-28,27,-29,-32,-33, and -35 and uses thereof
11/10/2010CN101883856A Influenza virus-like particles (VLPs) comprising hemagglutinin produced within a plant
11/10/2010CN101883789A Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
11/10/2010CN101880652A Recombinant Newcastle disease attenuated vaccine strain for expressing pig interferon (alpha, beta or gamma
11/10/2010CN101880651A Preparation method of Muscovy duck parvo novel vaccines
11/10/2010CN101879311A Method for preparing live vaccines of hog cholera and product thereof
11/10/2010CN101235364B Newcastle disease virus D90 strain and application thereof
11/10/2010CN101186902B Pseudorabies virus SA215, pseudorabies virus polygene deletion bacterin and preparation method thereof
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829329 Adenoviral vectors for treating disease
11/09/2010US7829102 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s)
11/09/2010CA2386242C Tumour-specific vector for gene therapy
11/09/2010CA2342305C Pestivirus mutants and vaccines containing the same
11/09/2010CA2328462C Efficient purification of adenovirus
11/04/2010WO2010125201A1 Recombinant virus-like particles encoded by multi-gene vector
11/04/2010WO2010125196A2 Bacteriophages specific to pak and cha strains of pseudomonas aeruginosa and their applications
11/04/2010WO2010124393A1 Anticancer agent comprising a yatapoxvirus mutant and uses thereof
11/04/2010WO2010056966A3 Novel hiv-2 isolate
11/04/2010US20100279968 Mutagenic Nucleoside Analogs for the Treatment of Viral Disease
11/04/2010US20100279894 Bacteriophages and coating material for surfaces
11/04/2010US20100279386 Modified vaccinia ankara virus variant and cultivation method
11/04/2010US20100279385 Purification of adenovirus and aav
11/04/2010US20100279384 Isolated reductive dehalogenase genes
11/04/2010US20100278865 Production and use of epitope-tagged hepatitis c virus particle
11/04/2010US20100278864 Rabies Vaccine
11/04/2010US20100278863 Reoviruses
11/04/2010US20100278858 Process for preparing attenuated viral strains
11/04/2010US20100278791 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same
11/04/2010US20100278773 Chimeric flavivirus vaccines
11/04/2010CA2760524A1 Recombinant virus-like particles encoded by multi-gene vector
11/03/2010EP2246419A1 Novel mycovirus, attenuated strain of phytopathogenic fungus, plant disease controlling agent, method of producing mycovirus, method of attenuating phytopathogenic fungus and method of controlling plant disease
11/03/2010EP2245154A2 Pre-or post-exposure treatment for filovirus or arenavirus infection
11/03/2010EP1478664B1 Tissue specific expression
11/03/2010EP1005376B1 Compositions for use in gene therapy for treatment of hemophilia
11/03/2010CN1895667B Reovirus inactivated vaccine and its preparation
11/03/2010CN1244215B Improved method for the production and purification of adenoviral vectors
11/03/2010CN101875931A siRNA recombinant slow virus for inhibiting human hephaestin gene expression and application
11/03/2010CN101875921A Method for separating and purifying hepatitis B virus particles
11/03/2010CN101875920A DcR3 (Decoy Receptor 3) and GAD65 (Glutamic Acid Decarboxylase 65) double gene co-expression recombinant adenovirus as well as preparation method and application thereof
11/03/2010CN101875919A Recombinant newcastle disease virus
11/03/2010CN101875918A Recombinant adenovirus of human hephaestin gene, preparation method thereof and application thereof
11/03/2010CN101875917A Method for producing swine fever vaccines by using animal cells cultured by micro-carriers of bio-reactor
11/03/2010CN101289655B Process for preparing porcine circovirus
11/02/2010US7824690 oncogenes; low pathogenicity
11/02/2010US7824689 immunogens; immunololgy; for production of vaccines; able to induce antiserum having neutralizing antibody; neutralization assay; Mareks Disease virus, infectious bronchitis virus, Newcastle disease virus, egg drop syndrome virus, turkey rhinotracheitis virus, or reovirus
11/02/2010CA2621088C Genetically engineered fowlpox-based vaccine strain
11/02/2010CA2459690C Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
11/02/2010CA2406100C Dna transfection system for the generation of infectious influenza virus
10/2010
10/28/2010WO2010123200A2 Bacteriophage which kills pathogenic enteric bacteria
10/28/2010WO2010122164A1 VIRUS-LIKE PARTICLES OF BACTERIOPHAGE φCB5
10/28/2010WO2010091262A8 Chimeric newcastle disease viruses and uses thereof
10/28/2010US20100275281 Multiple Inducible Gene Regulation System
10/28/2010US20100275278 Animal model for hiv induced disease
10/28/2010US20100273996 Method
10/28/2010US20100273669 Method for selecting a peptide or polypeptide which binds to a target
10/28/2010US20100273238 Cellular Permissivity Factor for Viruses and Uses Thereof
10/28/2010US20100273237 Processes for Packaging Oligonucleotides Into Virus-Like Particles of RNA Bacteriophages
10/28/2010US20100273145 Assay method utilizing polynucleotide sequences
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 267